SPECIES

WSU recruiting dogs to participate in drug metabolism study

WSU researchers are recruiting for a study they hope will lead to the development of a test to determine if a dog is at risk of significant adverse reactions to commonly used veterinary drugs. The Drugs Optimized by Genomics (D.O.G.) study is focused on a group of liver enzymes, the cytochrome P450, responsible for metabolizing drugs, chemicals and even contaminants from the environment.

Marnie, a pug owned by Alyssa Wolfe, rests on grass, Thursday, April 18, 2024, outside the Veterinary Teaching Hospital at Washington State University's College of Veterinary Medicine in Pullman. Marnie is taking part in the Drugs optimized by genetics (D.O.G.) clinical study that hopes to develop a drug sensitivity test to help veterinarians treat dogs with medications based on the animals’ genetics and individual needs. (College of Veterinary Medicine/Ted S. Warren)